If you are a patient who had sympathectomy - and the outcome was unexpected, - or if you are a medical professional who is well aware of the implications of surgical denervation, and share the concerns voiced in this petition, please add your name to it and mail it to the health minister.


You can contact Mia, ets.surgery@yahoo.com.au if you have any questions about this petition.

Sunday, November 18, 2012

Limited heart rate variability, autonomic nervous system imbalance implicated in Chronic Fatigue Syndrome

The Conversation: "The stress-response neural systems of chronic fatigue syndrome (CFS) patients remain on high alert even when they sleep, signalling that it’s not safe to relax, researchers have found.

Researchers also discovered that reduced heart rate variability, or changes in heart beat timing, are the best predictors of cognitive disturbances, such as concentration difficulties commonly reported by CFS sufferers. This adds to the growing body of evidence linking autonomic nervous system imbalance to this disorder.

The findings could lead to new ways to improve cognitive difficulties in people with CFS, which remains a poorly understood condition."


ETS result in limited (reduced) heart rate variability and alters the ANS (sympathetic and parasympathetic balance). This article might provide some insight into the cases where ETS resulted in a variety of unwelcome and detrimental side-effects, including fatigue, altered cognitive function ('brain fog'), etc.

Tuesday, November 13, 2012

No compensatory sweating after botulinum toxin treatment of palmar hyperhidrosis

No compensatory sweating after botulinum toxin... [Br J Dermatol. 2005] - PubMed - NCBI: "Recordings were made at 16 skin areas and compared with subjective estimates of sweating.
RESULTS:
Following treatment, palmar evaporation decreased markedly and then returned slowly towards pretreatment values, but was still significantly reduced 6 months after treatment. No significant increase of sweating was found after treatment in any nontreated skin area.
CONCLUSIONS:
Successful treatment of palmar hyperhidrosis with botulinum toxin does not evoke compensatory hyperhidrosis in nontreated skin territories."

'via Blog this'

Saturday, November 3, 2012

A randomized placebo-controlled trial of oxybuty... [J Vasc Surg. 2012] - PubMed - NCBI

"Palmar and axillary hyperhidrosis improved in >70% of the patients, and 47.8% of those presented great improvement. Plantar hyperhidrosis improved in >90% of the patients. Most patients (65.2%) showed improvements in their quality of life. The side effects were minor, with dry mouth being the most frequent (47.8%).
CONCLUSIONS:
Treatment of palmar and axillary hyperhidrosis with oxybutynin is a good initial alternative for treatment given that it presents good results and improves quality of life."

http://www.ncbi.nlm.nih.gov/pubmed/22341836